Fig. 2From: Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized studyKaplan-Meier curve for time to first moderate/severe COPD exacerbation (modified intent-to-treat population). BFF Budesonide/formoterol fumarate, BGF Budesonide/glycopyrrolate/formoterol fumarate, COPD Chronic obstructive pulmonary disease, GFF Glycopyrrolate/formoterol fumarate, MDI Metered dose inhalerBack to article page